| __timestamp | Ligand Pharmaceuticals Incorporated | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 2614539000 |
| Thursday, January 1, 2015 | 66107000 | 3711019000 |
| Friday, January 1, 2016 | 103402000 | 4560733000 |
| Sunday, January 1, 2017 | 135736000 | 5475166000 |
| Monday, January 1, 2018 | 245116000 | 6276700000 |
| Tuesday, January 1, 2019 | 108935000 | 7081200000 |
| Wednesday, January 1, 2020 | 156000000 | 7377200000 |
| Friday, January 1, 2021 | 214957000 | 13634200000 |
| Saturday, January 1, 2022 | 143418000 | 10612500000 |
| Sunday, January 1, 2023 | 96265000 | 11301400000 |
| Monday, January 1, 2024 | 12231500000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, financial performance is a key indicator of success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated have shown distinct trajectories in their gross profit trends. Regeneron has consistently outperformed Ligand, with its gross profit peaking at approximately $13.6 billion in 2021, a staggering 420% increase from 2014. In contrast, Ligand's growth has been more modest, with a peak in 2018 at around $245 million, marking a 340% increase from 2014. Despite Ligand's fluctuations, both companies have demonstrated resilience, adapting to market changes and challenges. As we look to the future, these trends offer valuable insights into the strategic maneuvers and market positioning of these pharmaceutical giants.
Gross Profit Analysis: Comparing Eli Lilly and Company and Ligand Pharmaceuticals Incorporated
Merck & Co., Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Ligand Pharmaceuticals Incorporated Trends
Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Regeneron Pharmaceuticals, Inc. and Alkermes plc Trends
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Gross Profit Analysis: Comparing Regeneron Pharmaceuticals, Inc. and MorphoSys AG
Gross Profit Comparison: Genmab A/S and Ligand Pharmaceuticals Incorporated Trends
Gross Profit Trends Compared: Viatris Inc. vs Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Grifols, S.A. vs Ligand Pharmaceuticals Incorporated